Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC. Reply
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
NRG1 Fusions: The New Kid on the Block.
Gupta B, Borghaei L, Liu S Curr Oncol Rep. 2025; 27(2):190-194.
PMID: 39888568 DOI: 10.1007/s11912-025-01640-y.
NRG1 Fusions in NSCLC: Being eNRGy Conscious.
Gupta B, Gosa Barrett L, Liu S Lung Cancer (Auckl). 2024; 15:143-148.
PMID: 39376790 PMC: 11457762. DOI: 10.2147/LCTT.S464626.
Two-to-One Randomization: Rarely Advisable.
Freidlin B, Korn E JCO Oncol Pract. 2024; 20(12):1555-1558.
PMID: 38986031 PMC: 11634641. DOI: 10.1200/OP.24.00217.